Clinical Trials Directory

Trials / Unknown

UnknownNCT05694754

Transcranial Magnetic Stimulation Theta Burst (TMS), Depression and Smoking.

Transcranial Magnetic Stimulation and Its Effects on Mayor Depressive Disorder and Smoking Cessation

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Dr. Julian Reyes López · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

This study evaluates de efficacy of Theta Burst Transcranial Magnetic Stimulation (TMS) applied on the left dorsolateral prefrontal cortex in patients with Major Depressive disorder and tobacco consumption.

Detailed description

Major Depressive Disorder (MDD) affects 350 million worldwide causing damage on quality of life and risk behavior such as suicide and smoking. smoking is the second leading cause of death causing about 5 million deaths annually. Theta Burst Stimulation (TBS) is a more tolerable protocol administered at lower intensities and shorter intervals than conventional rTMS protocols.

Conditions

Interventions

TypeNameDescription
DEVICETheta Burst Transcranial Magnetic StimulationMagventure MagPro R30 stimulation Device, MCF-B70 stimulation Coill

Timeline

Start date
2021-10-01
Primary completion
2022-12-01
Completion
2023-01-31
First posted
2023-01-23
Last updated
2023-01-23

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT05694754. Inclusion in this directory is not an endorsement.